eXoZymes, Inc.
EXOZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $121 | $83 | $87 | $134 |
| - Cash | $5 | $7 | $9 | $10 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $117 | $77 | $80 | $126 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.28 | -0.22 | -0.45 |
| % Growth | 3.6% | -27.3% | 51.1% | – |
| Operating Cash Flow | -$2 | -$2 | -$1 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$2 | -$2 | -$1 | -$6 |